Ligand profile
TR6
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00955 — DNA gyrase subunit A
Identifiers
Database identifiers and provenance.
- Ligand ID
TR6- PDB
4z2e- UniProt (similar protein)
Q8DPM2- Target protein
- KP13_00955
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 101.5
- −1 ≤ LogP ≤ 5 1.89
- MW ≤ 500 Da 416.4
- LogP ≤ 5 1.89
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 101.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(c(cc1F)F)N2C=C(C(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5N)C(=O)Oc1cc(c(cc1F)F)N2C=C(C(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5N)C(=O)O
InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16?InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16?
WVPSKSLAZQPAKQ-SOSAQKQKSA-NWVPSKSLAZQPAKQ-SOSAQKQKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00521' 'PF01751
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TR6 →
- PDB RCSB structure 4z2e →
- UniProt UniProt Q8DPM2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TR6”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00955.
PDB 24
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 16
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).